SCOPE (Skin Care in Organ Transplant Patients, Europe) Meeting
WORKSHOP
Wednesday 24th April 2019 | 09:00 - 12:30 | PETIT AMPHITHEATRE - Level 0
Chair : Deniz SECKIN (Turkey)
- Welcome and introduction
Deniz SECKIN (Turkey) - Melanoma in the context of organ transplantation: current issues and future outlooks
Christoph HOELLER (Austria), Alexandra GEUSAU (Austria) - Challenges for immunotherapy of Merkel cell carcinoma in organ transplant patients (including Q&A)
Jurgen BECKER (Germany) - Posttransplant Merkel cell carcinoma: what are the challenges and what does the SCOPE experience tell us?
Carla FERRÁNDIZ-PULIDO (Spain) - Tumor board: Case 1, Case 2 and Case 3
- Coffee break
- Management of the posttransplant advanced and high-stage cutaneous SCC: What are the difficulties, challenges and solutions? (including Q&A)
Chrysalyne SCHMULTS (United States) - Closing remarks and future perspectives
Charlotte PROBY (United Kingdom)
Controversies in Dermato-oncology I
WORKSHOP
Wednesday 24th April 2019 | 13:30 - 14:45 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Céleste LEBBE (France), Claus GARBE (Germany), Jean-Jacques GROB (France)
- Prevention campaign will prevent skin cancer - Yes
Alexander STRATIGOS (Greece) - Prevention campaign will prevent skin cancer - No
Claus GARBE (Germany) - Will lymph node surgery remain a main therapy in melanoma? - Yes
David MORENO-RAMIREZ (Spain) - Will lymph node surgery remain a main therapy in melanoma? - No
Axel HAUSCHILD (Germany) - Adjuvant therapy should be moved to primary melanoma stage II - Yes
Jean-Jacques GROB (France) - Adjuvant therapy should be moved to primary melanoma stage II - No
Paul LORIGAN (United Kingdom)
Controversies in Dermato-oncology II
WORKSHOP
Wednesday 24th April 2019 | 14:45 - 16:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Brigitte DRENO (France), Ketty PERIS (Italy), Alexander STRATIGOS (Greece)
- We should routinely measure quality of life of advanced melanoma patients - Yes
Carmen LOQUAI (Germany) - We should routinely measure quality of life of advanced melanoma patients - No
Isabelle BORGET (France) - Tumor mutational burden (TMB) will guide our future systemic treatments - Yes
- Tumor mutational burden (TMB) will guide our future systemic treatments - No
Olivier MICHIELIN (Switzerland) - Treatment of advanced melanoma: combining or sequencing? - Combining
Paolo ASCIERTO (Italy) - Treatment of advanced melanoma: combining or sequencing? - Sequencing
Dirk SCHADENDORF (Germany)
Opening Ceremony
PLENARY SESSION
Wednesday 24th April 2019 | 17:30 - 18:00 | AMPHITHEATRE LAVOISIER - Level 1
- New developments in occupational skin cancer: WHO disease burden project and implications for our patients
Sven Malte JOHN (Germany) - Welcome address
Céleste LEBBE (France)
Keynote lectures 1
PLENARY SESSION
Wednesday 24th April 2019 | 18:00 - 19:00 | AMPHITHEATRE LAVOISIER - Level 1
- The future of multiparametric immunofluorescence in melanoma beyond immunoscore
- The long journey from melanocyte to melanoma
Boris BASTIAN (United States) - Targeting innate immunity in cancer treatment
Eric VIVIER (France)
Management of advanced melanoma
WORKSHOP
Thursday 25th April 2019 | 08:30 - 09:30 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Paolo ASCIERTO (Italy), Thomas GAJEWSKI (United States), Caroline ROBERT (France)
Rare skin cancers and borderline neoplasms such as MELTUMP, clinic-pathological approach
WORKSHOP
Thursday 25th April 2019 | 08:30 - 10:30 | PETIT AMPHITHEATRE - Level 0
Chair : Petr ARENBERGER (Czech Republic), Boris BASTIAN (United States), Maxime BATTISTELLA (France), Matilda BYLAITE (Lithuania), Arnaud DE LA FOUCHARDIERE (France), Judit OLAH (Hungary)
- Adnexal Tumors
Maxime BATTISTELLA (France) - MELTUMP
Arnaud DE LA FOUCHARDIERE (France) - Neoplastic disorders of the nipple
Erika VARGA (Hungary) - Borderline vascular tumors
Matilda BYLAITE (Lithuania) - Soft tissue tumors
Judit OLAH (Hungary) - Overview on rare skin tumors
Petr ARENBERGER (Czech Republic)
Lymphoma
WORKSHOP
Thursday 25th April 2019 | 09:00 - 10:30 | ROOM 151 - Level 1
Chair : Martine BAGOT (France), Julia SCARISBRICK (United Kingdom), Rudolf STADLER (Germany)
- Tumor clone frequency is a robust predictor of progression and survival in patients with early stage mycosis fungoides
Adèle DE MASSON (France) - International landscape of therapies in CTCL, Results of the PROCLIPI Study
Pietro QUAGLINO (Italy) - Therapeutic Strategies for improved management in CTCL
Rudolf STADLER (Germany) - New monoclonal antibodies for the treatment of CTCL
Martine BAGOT (France) - Clinical endpoints updates and considerations for future staging
Julia SCARISBRICK (United Kingdom) - Management of Cutaneous B cell lymphoma
How to prevent Melanoma Progression in tumor-free patients of…
WORKSHOP
Thursday 25th April 2019 | 09:30 - 10:30 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Axel HAUSCHILD (Germany), Jean-Jacques GROB (France), Nicolas MEYER (France)
- Stage II
Jean-Jacques GROB (France) - Stage III
Axel HAUSCHILD (Germany) - Stage IV
Nicolas MEYER (France)
Trends in skin cancer epidemiology
WORKSHOP
Thursday 25th April 2019 | 11:00 - 12:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Sara GANDINI (Italy), Claus GARBE (Germany), David WHITEMAN (Australia)
- Incidence of melanoma in Europe 1950 - 2030
Claus GARBE (Germany) - Which percentage of melanoma is caused by UV radiation, and what proportion could be prevented?
David WHITEMAN (Australia) - Nevi and melanoma: who, when and how?
Sara GANDINI (Italy) - What do we achieve with screening examinations?
Andreas STANG (Germany)
Cases of adverse events in immuno-oncology
WORKSHOP
Thursday 25th April 2019 | 11:00 - 12:00 | PETIT AMPHITHEATRE - Level 0
Chair : Barouyr BAROUDJIAN (France), Lucie HEINZERLING (Germany), Christoph HOELLER (Austria)
Biomarkers in melanoma
WORKSHOP
Thursday 25th April 2019 | 11:00 - 12:00 | ROOM 151 - Level 1
Chair : John HAANEN (Netherlands), Olivier MICHIELIN (Switzerland), Selma UGUREL (Germany)
Keynote lectures 2
PLENARY SESSION
Thursday 25th April 2019 | 12:00 - 13:00 | AMPHITHEATRE LAVOISIER - Level 1
- Where and when will melanoma incidence decrease?
David WHITEMAN (Australia) - How to modulate tumor microenvironment?
Thomas GAJEWSKI (United States) - Molecular resistance to targeted therapy, from bench to bedside
Grant Mc ARTHUR (Australia)
Prevention and skin cancer screening
WORKSHOP
Thursday 25th April 2019 | 14:00 - 15:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Véronique DEL MARMOL (Belgium), Ana Maria FORSEA (Romania), Eduardo NAGORE (Spain)
Actinic keratosis and field cancerisation
WORKSHOP
Thursday 25th April 2019 | 14:00 - 15:00 | ROOM 151 - Level 1
Chair : Ketty PERIS (Italy), Eggert STOCKFLETH (Germany), Nicole KELLENERS-SMEETS (Netherlands)
Free communications 1
FREE COMMUNICATIONS
Thursday 25th April 2019 | 14:00 - 15:00 | PETIT AMPHITHEATRE - Level 0
Chair : Sophie DALAC-RAT (France), Lionel LARUE (France), Charlotte PROBY (United Kingdom)
Non surgical local tumor treatment
WORKSHOP
Thursday 25th April 2019 | 16:30 - 18:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Christoph HOELLER (Austria), Ricardo VIEIRA (Portugal), Philippe SAIAG (France)
Brain metastases
WORKSHOP
Thursday 25th April 2019 | 16:30 - 18:00 | ROOM 151 - Level 1
Chair : Emilie LE RHUN (France), Friedegund MEIER (Germany), Hussein TAWBI (United States)
Free communications 2
FREE COMMUNICATIONS
Thursday 25th April 2019 | 16:30 - 18:00 | PETIT AMPHITHEATRE - Level 0
Chair : Stéphane DALLE (France), Helen GOGAS (Greece), Janice MEHNERT (United States)
Neoadjuvant therapy
WORKSHOP
Friday 26th April 2019 | 08:30 - 09:30 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Christian BLANK (Netherlands), James LARKIN (United Kingdom), Peter MOHR (Germany)
Dermoscopy and confocal microscopy
WORKSHOP
Friday 26th April 2019 | 08:30 - 09:30 | ROOM 151 - Level 1
Chair : Giovanni PELLACANI (Italy), Luc THOMAS (France), Iris ZALAUDEK (Austria)
The role of skin cancer centers: clinical care, quality assurance, data banking, teaching, research and innovation...
WORKSHOP
Friday 26th April 2019 | 08:30 - 10:30 | PETIT AMPHITHEATRE - Level 0
Chair : Claus GARBE (Germany), Lidija KANDOLF-SEKULOVIC (Serbia and Montenegro), Dirk SCHADENDORF (Germany), Lise BOUSSEMART (France)
Practical tips for your surgical work
WORKSHOP
Friday 26th April 2019 | 09:30 - 10:30 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Florence CORGIBET (France), Roland KAUFMANN (Germany), Vernon SONDAK (United States)
- Before and after surgical procedures
Florence CORGIBET (France) - Surgical procedures for the primary tumour
Roland KAUFMANN (Germany) - About the sentinel node biopsies and nodal dissections
Vernon SONDAK (United States)
New technologies for the diagnosis of skin cancer: from computer vision (automatized diagnosis) to innovation in photonics
WORKSHOP
Friday 26th April 2019 | 09:30 - 10:30 | ROOM 151 - Level 1
Chair : Véronique DEL MARMOL (Belgium), Josep MALVEHY (Spain), Nesrine BRAHIMI (France)
New therapeutic targets in melanoma
WORKSHOP
Friday 26th April 2019 | 11:00 - 12:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Brigitte DRENO (France), Grant Mc ARTHUR (Australia)
Update on the skin cancers in immunosuppressed patients, on behalf of SCOPE
WORKSHOP
Friday 26th April 2019 | 11:00 - 12:00 | ROOM 151 - Level 1
Chair : Emilie DUCROUX (France), Catherine HARWOOD (United Kingdom), Deniz SECKIN (Turkey)
- Introduction
Deniz SECKIN (Turkey) - What is new in the pathogenesis and treatment of posttransplant Kaposi's sarcoma?
Stéphane BARETE (France) - The role and therapeutic implications of HPV presence in posttransplant squamous cell carcinoma: SCOPE research update
Jan Nico BOUWES-BAVINCK (Netherlands) - Skin field cancerization: Converging transcription/ epigenetic regulatory pathways of translational value
Paolo DOTTO (Switzerland)
Best posters session
FREE COMMUNICATIONS
Friday 26th April 2019 | 11:00 - 12:00 | PETIT AMPHITHEATRE - Level 0
Chair : Ralf GUTZMER (Germany), Gaëlle QUEREUX (France), Henri MONTAUDIE (France)
Keynote lectures 3
PLENARY SESSION
Friday 26th April 2019 | 12:00 - 13:00 | AMPHITHEATRE LAVOISIER - Level 1
- Biology and therapy of Merkel cell carcinoma
Paul NGHIEM (United States) - Raising the efficacy in immunotherapy of melanoma: what are we going to achieve?
- Targeting pathways in basal cell carcinoma: sonic hedgehog and beyond
Nicole BASSET-SEGUIN (France)
Management of advanced BCC and SCC
WORKSHOP
Friday 26th April 2019 | 14:00 - 15:30 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Nicole BASSET-SEGUIN (France), Ulrike LEITER (Germany), Alexander STRATIGOS (Greece)
- General principles of management of NMSC
Alexander STRATIGOS (Greece) - Surgery in advanced tumors (SCC and BCC)
David MORENO-RAMIREZ (Spain) - Systemic treatment of advanced BCC
Nicole BASSET-SEGUIN (France) - Systemic Treatment of advanced SCC
Ulrike LEITER (Germany) - Expert panel discussion: Difficult to treat BCC- challenging cases
Matilda BYLAITE (Lithuania) - Expert panel discussion: Difficult to treat SCC- challenging cases
Ingrid WOLF
What is new in melanoma biology?
WORKSHOP
Friday 26th April 2019 | 14:00 - 15:30 | PETIT AMPHITHEATRE - Level 0
Chair : Boris BASTIAN (United States), Nicolas DUMAZ (France), Amaya VIROS (United Kingdom)
- Nongenetic mechanisms as drivers of tumor evolution and therapy resistance
Jean-Christophe MARINE (Belgium) - TERT promoter mutations, telomere length and melanoma survival and risk
Rajive KUMAR (Germany) - Novel roles of ROCK-Myosin II in melanoma
Victoria SANZ-MORENO (United Kingdom) - Neural Crest Stemness in Melanoma
Lukas SOMMER (Switzerland)
Virus induced cancer
WORKSHOP
Friday 26th April 2019 | 14:00 - 15:30 | ROOM 151 - Level 1
Chair : Jurgen BECKER (Germany), Nicolas DUPIN (France), Paul NGHIEM (United States)
- Immunobiology of Merkel cell carcinoma
Jurgen BECKER (Germany) - Progress and challenges in Merkel cell carcinoma management
Paul NGHIEM (United States) - Update on oncogenesis and therapy for Kaposi’s sarcoma
Nicolas DUPIN (France)
What is new in NMSC biology?
WORKSHOP
Friday 26th April 2019 | 17:00 - 18:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Irene LEIGH (United Kingdom), Dany NASSAR (France), Chrysalyne SCHMULTS (United States)
- Mechanisms of Resistance to Hedgehog/Smoothened Inhibitors in BCC
Mike MIDGEN (United States) - Regulation of Epithelial Mesenchymal Transition in SCC
Dany NASSAR (France) - Squamous Carcinogenesis: Commonalities and Difference Across Epithelial Cell Types
Catherine HARWOOD (United Kingdom) - Molecular Prediction of Recurrence and Metastasis in SCC
Chrysalyne SCHMULTS (United States)
Genodermatoses and associated cancers
WORKSHOP
Friday 26th April 2019 | 17:00 - 18:00 | ROOM 151 - Level 1
Chair : Susanna PUIG (Spain), Pierre VABRES (France), Pierre WOLKENSTEIN (France)
Free communications 3
FREE COMMUNICATIONS
Friday 26th April 2019 | 17:00 - 18:00 | PETIT AMPHITHEATRE - Level 0
Chair : Véronique BATAILLE (United Kingdom), Julie DELYON (France), Caroline GAUDY (France)
Dermoscopy and confocal microscopy cases
WORKSHOP
Saturday 27th April 2019 | 08:30 - 09:30 | ROOM 151 - Level 1
Chair : Philippe BAHADORAN (France), Ralph BRAUN (Switzerland), Josep MALVEHY (Spain)
Interactive cases: management of difficult to treat carcinomas
WORKSHOP
Saturday 27th April 2019 | 08:30 - 11:00 | AMPHITHEATRE LAVOISIER - Level 1
Chair : Jean-Jacques GROB (France), Eve MAUBEC (France), Chrysalyne SCHMULTS (United States), Victor FARRICHA (Portugal)
Dermoscopy and confocal microscopy cases
WORKSHOP
Saturday 27th April 2019 | 09:30 - 10:30 | ROOM 151 - Level 1
Chair : Harald KITTLER (Austria), Aimilios LALLAS (Greece), Iris ZALAUDEK (Austria)
- When dermoscopy is straight forward
Aimilios LALLAS (Greece) - When dermoscopy is not straight forward
Harald KITTLER (Austria) - When confocal is of help
Caterina LONGO - Pre- and intra-operative use of non-invasive techniques
Susanna PUIG (Spain)
Keynote lectures 4
PLENARY SESSION
Saturday 27th April 2019 | 11:30 - 12:30 | AMPHITHEATRE LAVOISIER - Level 1
- What's new in non melanoma skin cancer?
Brigitte DRENO (France) - What's new in melanoma?
Olivier MICHIELIN (Switzerland) - What's new in cutaneous lymphoma?
Marie BEYLOT-BARRY (France)